ProPublica video traces where generic drugs come from

· Investigations · United States

ProPublica has published a video investigating where generic drugs come from, following its reporting on the global supply chain behind low-cost medicines. The piece examines the manufacturing and sourcing chain that brings generics to patients, a topic that gained prominence as drug shortages and quality concerns drew attention to overseas production. The item is a video companion to prior reporting and gives few new specifics in the headline alone, and does not name companies or regulators. Generic medicines account for the large majority of prescriptions in many markets, so visibility into their production is central to debates over drug safety, supply resilience and regulation of overseas plants. The immediate effect is to put the sourcing question in front of a wider audience through visual reporting.

Why it matters：Supply-chain transparency for generic medicines underpins debates over drug safety and resilience, and investigations like this shape scrutiny of overseas manufacturing.

Key points

  • The video follows ProPublica's reporting on the generic-drug supply chain.
  • It examines where generic medicines are made and sourced.
  • The item does not name specific companies or regulators.

Sources (original reporting)

More stories from this day